CLINICAL_TRIALS
trial_result
· 2024-12-10
Clinical Trial Update: Skin Autofluorescence as a Risk Marker in People Receiving Dialysis.
Summary
A completed clinical trial evaluated whether skin autofluorescence could serve as a risk marker in patients with Chronic Kidney Disease on dialysis. Results wer…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Nottingham | Conditions: Chronic Kidney Disease | Status: COMPLETED | Results posted: 2024-12-10